Search - tctmd.com

Displaying 521 - 540 of 982

Sort: Relevancy | Date

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo

L.A. McKeown

August 24, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Industry News

EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval

August 15, 2016

News Daily News

CLEAN-TAVI: Se Publican los Resultados de Protección Embólica Cerebral en TAVR

Yael L. Maxwell

August 15, 2016

News Daily News

CLEAN-TAVI: Results of Cerebral Embolic Protection in TAVR Now in Print

Yael L. Maxwell

August 15, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

Aortic Complications Spike for Women During Pregnancy and Shortly After Giving Birth

Caitlin E. Cox

August 09, 2016

News Daily News

CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality

Yael L. Maxwell

August 05, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Todd Neale

August 01, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2016

Shelley Wood

July 28, 2016

News Daily News

Blood Test May Be Useful for Detecting Aortic Regurgitation During TAVR

L.A. McKeown

July 27, 2016

News Daily News

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Michael O'Riordan

July 25, 2016

News Daily News

Los Altos Índices de Hemorragias Gastrointestinales Superiores Post-TAVR Plantean Dudas para los Antitrombóticos y ETE

Yael L. Maxwell

July 22, 2016

News Daily News

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

Todd Neale

July 14, 2016

News Daily News

Sapien 3: Results for High-Risk, Inoperable TAVR Patients Now in Print

Yael L. Maxwell

July 12, 2016

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

Advertisement

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Mejor Supervivencia y Ausencia de ‘Tendencia de Riesgo’ para TAVR vs Cirugía en Pacientes de Menor Riesgo

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval

CLEAN-TAVI: Se Publican los Resultados de Protección Embólica Cerebral en TAVR

CLEAN-TAVI: Results of Cerebral Embolic Protection in TAVR Now in Print

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Aortic Complications Spike for Women During Pregnancy and Shortly After Giving Birth

CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

TCTMD’s Top 10 Most Popular Stories for July 2016

Blood Test May Be Useful for Detecting Aortic Regurgitation During TAVR

Un Sistema Simple de Puntuación del Riesgo Predice la Mortalidad Post-TAVR

Los Altos Índices de Hemorragias Gastrointestinales Superiores Post-TAVR Plantean Dudas para los Antitrombóticos y ETE

Combining Off-Pump CABG and Transaortic TAVR May Be an Option in Some Cases

Sapien 3: Results for High-Risk, Inoperable TAVR Patients Now in Print

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

TCTMD’s Top 10 Most Popular Stories for June 2016

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content